# Comparison Between Dual Energy/Subtraction CT With MRI for the Identification of Predictors of Malignancy in Cystic Pancreatic Lesions

> **NCT03320733** · NA · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 46 (actual)

## Conditions studied

- Pancreatic Cyst

## Interventions

- **DIAGNOSTIC_TEST:** Dual energy CT scan with subtraction imaging

## Key facts

- **NCT ID:** NCT03320733
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03320733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03320733, "Comparison Between Dual Energy/Subtraction CT With MRI for the Identification of Predictors of Malignancy in Cystic Pancreatic Lesions". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03320733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*